OM2.F ORTHOFIX MED.INC. DL-10

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
6.20 EUR
Close of Nov 12, 2026
6.10 13.70
Market cap
EUR 253M
P/E
-
P/B
0.65x
ROE
-13.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is OM2.F undervalued?

Graham number

The Graham number of ORTHOFIX MED.INC. DL-10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ORTHOFIX MED.INC. DL-10 fundamental analysis

No fundamental analysis for ORTHOFIX MED.INC. DL-10 yet.

ORTHOFIX MED.INC. DL-10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ORTHOFIX MED.INC. DL-10

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation impl…

Full company profile